Global Fluoxetine Market, By Drug Class (Antidepressant, Selective Serotonin Reuptake Inhibitor (SSRI)), Application (Obsessive-Compulsive Disorder, Panic Disorder, Depression, Bulimia Nervosa, Others), Demographic (Adult, Pediatric, Geriatric), Dosage Form (Tablet, Solution, Capsule, Syrup, Others), Route of Administration (Oral, Others), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2029
read more..